English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Zaremba H. E., Virnaya M.M.

    DEPENDENCE LIPID ABNORMALITIES IN PATIENTS WITH HYPERTENSION ON THE LEVEL INFLAMMATION


    About the author: Zaremba H. E., Virnaya M.M.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation This article is devoted to studying the links between lipid spectrum of the blood and systemic inflammation. Positive correlations between indicators of systemic inflammation and blood pressure indicate inflammation involved in the pathogenesis of hypertension and target organ damage. Established relationships between indicators of systemic inflammation and lipidohramy indicate metabolic conditioning units hyperactivity cytokine immunoregulation.
    Tags hypertension, blood lipid profile, systemic inflammation
    Bibliography
    • Vostrikova N. V. Markyoryi vospalitelnoy reaktsii (s-reaktivnyiy belok i interleykin-6) pri arterialnoy gipertenzii / N. V. Vostrikova, D. V. FYodorov, A. N. Mamaev [ta in.] // Sibirskiy meditsinskiy zhurnal. – 2009. – No.4. – S. 33–35.
    • Vyunitska L. V. S-reaktivniy bilok u laboratorniy diagnostitsi y otsintsi riziku aterosklerozu / L. V. Vyunitska, G. G. Lunova. // Zb. nauk. sprats spIvrobIt. NMAPO im. P.L. Shupika. – 2014. – No.23. – S. 522–528.
    • Dislipidemiyi: diagnostika, profilaktika ta likuvannya. Metodichni rekomendatsiyi asotsiatsiyi kardiologiv Ukrayini. - K., - 2011.
    • Koval S. N. Narushenie purinovogo obmena i arterialnaya gipertenziya / S. N. Koval, V. V. Bozhko, O. V. Misnichenko // Ukrayinskiy revmatologichniy zhurnal. - 2009. – No. 4(38). - S. 75-80.
    • Koval S. M. Giperurikemiya ta sumarniy rizik uskladnen u patsientiv iz gipertonichnoyu hvoroboyu (za danimi klinichnogo doslidzhennya) / S. M. Koval, V. V. Bozhko, M. Yu. Penkova [ta in.] //Ukrayinskiy revmatologIchniy zhurnal.– 2010.– No.4.– S.42-48.
    • Kravchun P. G. Osoblivosti zmin markeriv zapalennya u hvorih na ishemichnu hvorobu sertsya z ozhirinnyam / P.G. Kravchun, M.O. Shelest, Yu.O. Kovalova [ta in.] // Med. sogodni i zavtra. – 2013. – No. 2 (59). – S. 38-42.
    • Luchko O. R. Zvyazok pokaznikIv sistemnogo zapalennya ta endotelialnoyi disfunktsiyi u hvorih na hronichniy pielonefrit z arterialnoyu gipertenzieyu / O. R. Luchko. // Bukovinskiy medichniy visnik. – 2013. – No.1. – S. 59–64.
    • Ridker P. M. JUPITER Study Group. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) / P. M. Ridker, J.G. MacFadyen, F. A. Fonseca [et al.] // Circulat. Cardiovasc. Qual. Outcomes. - 2009. - 2, 6. - 616–623.
    • 2013 ESH/ESC Guidelines for the management of arterial hypertension TheTask Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC) // Journal of Hypertension. - 2013. - Vol. 31. - P. 1281-1357.
    Publication of the article «World of Medicine and Biology» №1(59), 2017 year, 058-061 pages, index UDK 612.307:616-002-036.8:516:12-008.331.1-05